Echinacea
Echinacea purpurea — also: Purple coneflower
Evidence is genuinely mixed — some trials show small benefit for cold duration, others none.
Used by Indigenous peoples of North America for infections and wounds; later adopted in European/American herbalism for colds.
May slightly reduce the duration or risk of the common cold.
Polysaccharides/alkamides may modulate immune cell activity; effects vary by species and preparation.
- Possible small reduction in cold duration
Meta-analyses are mixed; some show modest benefit, product variability is high.
- Species/preparation differences
- Inconsistent trial results
- Allergy (ragweed/daisy family)
- GI upset
- People with autoimmune disease or daisy-family allergy
GI upset, rash; allergic reactions, especially in those allergic to ragweed/daisies.
Theoretical interaction with immunosuppressants; caution in autoimmune conditions.
Insufficient data in pregnancy; avoid in autoimmune disease without advice.
Hardy garden perennial; harvest roots in autumn of mature plants.
- Some Cochrane-reviewed trials show a small reduction in cold incidence or duration; others show none.
- Effects appear product- and species-dependent (E. purpurea aerial vs. root vs. E. angustifolia).
- No reliable evidence it 'boosts immunity' in a general, lasting way.
Extreme product heterogeneity makes pooling difficult; the honest verdict is uncertainty.
Standardized, well-characterized preparations tested in large trials with prespecified endpoints.
A maybe, not a guarantee — variability between products is the real story.